Topic: Dow Jones & Co. Inc.

Bonuses For GSK Pharma Sales Reps Won’t Be Tied to Sales

When GlaxoSmithKline said that bonuses for its U.S. pharma sales reps will no longer be based on, you know, sales, we needed to know more!. Tying bonuses to "company values" discourages sales reps from pushing unapproved uses of drugs and has become ...
New Novartis chief Joe Jimenez (right) is looking at beefing up some business segments with acquisitions, but has nothing in mind as big as its $39.3 billion plan to buy the rest of eye-care company Alcon.. "We may go for smaller, bolt-on ...

Drug-Maker Pens Are Endangered Species at Cancer Confab

Many doctors attending ASCO, the big annual cancer conference, are leaving empty-handed this year.. Here's how Thomas Gryta of Dow Jones Newswires describes the somber scene: "According to booth workers, traffic is drastically lower, and they blame the lack of giveaways. The ...

Big Pharma Execs Say Recession Will Hurt; DTC Was ‘Worst Decision’

People who thought health care is recession-proof are wrong, says AstraZeneca's CEO David Brennan. "While it's true people need health care regardless of the economy," the recession will be "deep and long," Brennan (pictured) said at a Financial Times conference in London. ...

Big Pharma Execs Say Recession Will Hurt; DTC Was 'Worst Decision'

People who thought health care is recession-proof are wrong, says AstraZeneca's CEO David Brennan. "While it's true people need health care regardless of the economy," the recession will be "deep and long," Brennan (pictured) said at a Financial Times conference in London. ...

More Job Cuts at Sanofi, This Time in the US

Chris Viehbacher,the new CEO of Sanofi-Aventis, isn't a man to let the grass grow under his feet. Just two days in his new job, and Sanofi is cutting its U.S. sales force, Dow Jones Newswires reports. It's unclear exactly how many of ...

Q2 Earnings Coming Soon: J&J, Amgen, Merck, Pfizer and Genentech

It seems like we just finished blogging first-quarter earnings, but the season is upon us again. At this point, the key question for Amgen is what happens with its experimental bone drug denosumab. For Genentech, it was the first full quarter with ...

Merck Searches for Goldilocks Biotech

As Merck continues its post-Vioxx makeover, the company is prowling for a nice biotech company to buy.. Merck CEO Richard Clark told Dow Jones Newswires' Peter Loftus that the "perfect" deal would be a company with a mid-sized market cap, some products ...

'Le Weekend' Pill Gets French Sales Partner in America

Sanofi-Aventis of France is partnering with Eli Lilly of America's heartland to give Lilly's impotence pill Cialis a boost over here. The effects of Cialis can last as long as 36 hours, earning it the nickname "Le Weekend" pill on the Continent. ...

‘Le Weekend’ Pill Gets French Sales Partner in America

Sanofi-Aventis of France is partnering with Eli Lilly of America's heartland to give Lilly's impotence pill Cialis a boost over here. The effects of Cialis can last as long as 36 hours, earning it the nickname "Le Weekend" pill on the Continent. ...